Analytical Data
-
Gene name
EM2
- Application
-
Alternative Names
EM2；
-
Species
E.coli
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P0DX32
-
Expression Region
1-14aa
-
AA Sequence
LKLLGIVKKVLGAI
-
Molecular Weight
1.4 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The study of EM2 recombinant proteins is grounded in the broader field of protein science and biotechnology, focusing on the application of genetic engineering to produce proteins with specific functions. EM2, a protein derived from the mammalian system, has garnered interest due to its unique structural and functional properties, which may have implications in various fields such as therapeutics and biomaterials. The recombinant production of EM2 offers advantages over traditional extraction methods, allowing for higher yields, enhanced purity, and the possibility of post-translational modifications that can optimize its biological activity. Researchers are particularly interested in EM2’s role in cellular signaling, its potential impact on metabolic pathways, and its applications in drug development, aiming to harness its properties for innovative treatments. The ongoing exploration of EM2 not only contributes to our understanding of protein dynamics but also paves the way for advancements in medicine and biotechnology, particularly in the design of novel therapeutic agents and diagnostic tools. By utilizing advanced techniques in molecular biology and bioengineering, scientists are working towards elucidating the mechanisms of action of EM2, which can lead to breakthroughs in managing various diseases and enhancing the efficacy of existing treatments. The promising results from EM2 research thus highlight the importance of recombinant proteins in modern science, showcasing their potential to address significant unmet medical needs.
